AyeleA,Gebre-SelassieS.,Hepatitis C Virus,,2013,Infections among Patients with Chronic Liver Diseases in Public Hospitals in Addis Ababa, Ethiopia,ISRN Tropical Med,,1,7
SchaeferM,CapuronL,FriebeA,Diez-QuevedoC,RobaeysG,NeriS,,2012,Hepatitis C infection, antiviral treatment and mental health: a European expert consensus statement,J Hepatol,57,1379,90
QureshiH,BileK,JoomaR,AlamS,AfridiH,,2010,Prevalence of hepatitis B and C viral infections in Pakistan: findings of a national survey appealing for effective prevention and control measures,Eastern Med Health J,16,S15,
FarooqiJI,FarooqiRJ,,2008,Conventional interferon alfa-2b and ribavirin for 12 versus 24 weeks in HCV genotype 2 or 3,J Coll Physicians Surg Pak,18,620,4
RehanHS,ManakS,YadavM.,,2014,Supervised conventional interferon ?2a in combination with ribavirin therapy is the preferred alternative for treatment of chronic hepatitis C,Ind J Pharmacol,46,490,2
EslamM,KhattabM,Harrison S,,2011,Peroxisome proliferator-activated receptors and hepatitis C virus,Therapeut Adv Gastroenterol,4,419,31
Deltenre P, Louvet A, Lemoine M, Mourad A, Fartoux L, Moreno C,
et al. Impact of insulin resistance on sustained response in HCV
patients treated with pegylated interferon and ribavirin: a metaanalysis.
J Hepatol 2011; 55: 1187-94.
YuJW,SunLJ,ZhaoYH,KangP,YanBZ,,2012,The effect of metformin on the efficacy of antiviral therapy in patients with genotype 1 chronic hepatitis C and insulin resistance,Int J Infect Dis,16,e436,e41
ChojkierM,ElkhayatH,SabryD,DonohueM,BuckM.,,2012,Pioglitazone decreases hepatitis C viral load in overweight, treatment naive, genotype 4 infected-patients: a pilot study,PloS one,7,e31516,
HarrisonSA,HamzehFM,HanJ,PandyaPK,SheikhMY,VierlingJM,,2012,Chronic hepatitis C genotype 1 patients with insulin resistance treated with pioglitazone and peginterferon alpha-2a plus ribavirin,Hepatology,56,464,73
AlbertiA,VarioA,FerrariA,PistisR,,2005,Review article: chronic hepatitis C-natural history and cofactors,Alimentary Pharmacol Therapeut,22,74,8
Romero-GómezM,Del Mar ViloriaM,AndradeRJ,SalmerónJ,DiagoM,Fernández-RodríguezCM,,2005,Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients,Gastroenterology,128,636,41
AsselahT,Rubbia-BrandtL,MarcellinP,NegroF.,,2006,Steatosis in chronic hepatitis C: why does it really matter,Gut,55,123,30
Negro F.,,2006,Insulin resistance and HCV: will new knowledge modify clinical management,J Hepatol,45,514,9
GinesP,AngeliP,LenzK,MollerS,MooreK,Moreu R. European,DeltenreP,LouvetA,LemoineM,MouradA,FartouxL,MorenoC,,2011,Impact of insulin resistance on sustained response in HCV patients treated with pegylated interferon and ribavirin: a metaanalysis,J Hepatol,55,1187,94
Deltenre P, Louvet A, Lemoine M, Mourad A, Fartoux L, Moreno C,
et al. Impact of insulin resistance on sustained response in HCV
patients treated with pegylated interferon and ribavirin: a metaanalysis.
J Hepatol 2011; 55: 1187-94.
Overbeck K, Genné D, Golay A, Negro F, Liver SAftSot. Pioglitazone
in chronic hepatitis C not responding to pegylated interferon-?
and ribavirin. J Hepatol 2008; 49: 295-8.
Romero Gómez M, Diago M, Andrade RJ, Calleja JL, Salmerón J,
Fernández Rodríguez CM, et al. Treatment of insulin resistance
with metformin in naïve genotype 1 chronic hepatitis C patients
receiving peginterferon alfa 2a plus ribavirin. Hepatology 2009;
50:1702-8.
Khattab M, Emad M, Abdelaleem A, Eslam M, Atef R, Shaker Y, et
al. Pioglitazone improves virological response to peginterferon
??2b/ribavirin combination therapy in hepatitis C genotype 4
patients with insulin resistance. Liver Int 2010; 30: 447-54